Exelixis Tightens 340B Contract Pharmacy Restrictions, Adds Claims Data Requirements
An oncology-focused biotech company recently announced it will soon set new limits on where it ships 340B-priced products and require [...]
*Sign up for news summaries and alerts from 340B Report